ClinicalTrials.Veeva

Menu

Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

U

University of Cologne

Status

Unknown

Conditions

Infective Endocarditis

Study type

Observational

Funder types

Other

Identifiers

NCT02388893
14-221 (Other Identifier)

Details and patient eligibility

About

As recommended in the Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (IE) patients with IE should be evaluated and managed by a multispecialty team including an cardiologist, infectious disease specialist, and cardiac surgeon. Our registry is a prospective, national registry of patients with IE. From January 2013 data from endocarditis board were prospectively recorded using standard definitions during the hospitalization. Patient demographics, clinical, laboratory, and imaging data at the time of IE diagnosis, as well as treatment outcomes were entered into the ER-UHC database.

Full description

The primary endpoint will be the 1 year all-cause mortality after treatment begins of IE. We will use 1 year all-cause mortality as the primary endpoint because it has been demonstrated that a period of at least 6 months is necessary to offset the early postoperative mortality related to valve surgery. We also looked at all-cause in-hospital mortality as a secondary endpoint.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with patients with definitive infective endocarditis

Exclusion criteria

  • childs

Trial contacts and locations

1

Loading...

Central trial contact

Guido Michels, Prof. Dr.; Norma Jung, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems